Oncimmune

Immunodiagnostics company developing biomarker platforms for cancer and immune diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2006 groups62 employees language oncimmune.com

Registered entities

Social engagement

Social engagement: 5.7K social following, 4 posts in the last 12 months — around the industry typical range.

Investor mix

11 investors on record.

Investor typeCountShare
Venture capital436%
Private equity218%
Bank & private debt218%
Other / undisclosed327%

Recent activity

4 Mar 2026
Event
Alden Scientific CEO Jamie Heywood at The National Academies of Sciences, Engineering, and Medicine
17 Feb 2026
Event
BIOEuropeSpring
Coming soon